These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21602431)

  • 1. Obesity and type 2 diabetes: what can be unified and what needs to be individualized?
    Eckel RH; Kahn SE; Ferrannini E; Goldfine AB; Nathan DM; Schwartz MW; Smith RJ; Smith SR; ; ;
    Diabetes Care; 2011 Jun; 34(6):1424-30. PubMed ID: 21602431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and type 2 diabetes: what can be unified and what needs to be individualized?
    Eckel RH; Kahn SE; Ferrannini E; Goldfine AB; Nathan DM; Schwartz MW; Smith RJ; Smith SR
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1654-63. PubMed ID: 21602457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
    Grams J; Garvey WT
    Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus.
    Leahy JL; Hirsch IB; Peterson KA; Schneider D
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4206-16. PubMed ID: 20739389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy considerations in diabetes and obesity: setting patients up for success.
    Cornell S; D'Souza J
    Postgrad Med; 2014 Mar; 126(2):100-9. PubMed ID: 24685973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for obesity in menopausal women.
    Samat A; Rahim A; Barnett A
    Menopause Int; 2008 Jun; 14(2):57-62. PubMed ID: 18519266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
    Baretić M; Troskot R
    Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know.
    Smith RJ; Nathan DM; Arslanian SA; Groop L; Rizza RA; Rotter JI
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1566-74. PubMed ID: 20194712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs?
    Flatt PR
    Diab Vasc Dis Res; 2007 Jun; 4(2):151-3. PubMed ID: 17654450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes and obesity in adults.
    Whitmore C
    Br J Nurs; 2010 Jul 22-Aug 11; 19(14):880, 882-6. PubMed ID: 20647979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The success of bariatric surgery as treatment of type 2 diabetes should be a call to revitalize anti-obesity drug discovery and development.
    Opgenorth TJ
    Curr Opin Investig Drugs; 2008 Apr; 9(4):355-6. PubMed ID: 18393101
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical and surgical management of obesity and diabetes: what's new?
    Ammori BJ; Skarulis MC; Soran H; Syed AA; Eledrisi M; Malik RA
    Diabet Med; 2020 Feb; 37(2):203-210. PubMed ID: 31850536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orlistat in the treatment of Type 2 diabetes mellitus.
    Kelley DE; Jneidi M
    Expert Opin Pharmacother; 2002 May; 3(5):599-605. PubMed ID: 11996637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrupting the natural history of diabetes mellitus: lifestyle, pharmacological and surgical strategies targeting disease progression.
    Khavandi K; Brownrigg J; Hankir M; Sood H; Younis N; Worth J; Greenstein A; Soran H; Wierzbicki A; Goldsmith DJ
    Curr Vasc Pharmacol; 2014 Jan; 12(1):155-67. PubMed ID: 22272898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes.
    Scheen AJ; Van Gaal LF
    Lancet Diabetes Endocrinol; 2014 Nov; 2(11):911-22. PubMed ID: 24731666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies.
    Merlotti C; Morabito A; Pontiroli AE
    Diabetes Obes Metab; 2014 Aug; 16(8):719-27. PubMed ID: 24476122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on obesity pharmacotherapy.
    Velazquez A; Apovian CM
    Ann N Y Acad Sci; 2018 Jan; 1411(1):106-119. PubMed ID: 29377198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic options for metabolic syndrome in obese patients].
    Carella AM; Conte M
    Clin Ter; 2007; 158(5):457-64. PubMed ID: 18062354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [And what about diabetes?].
    Cerasi E
    Bull Acad Natl Med; 2007; 191(4-5):941-3; discussion 943. PubMed ID: 18225448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.